3-(4-BENZYL-PIPERIDIN-1-YL)-PROPYLAMINE
![]() |
- $485 - $874
- Product name: 3-(4-BENZYL-PIPERIDIN-1-YL)-PROPYLAMINE
- CAS: 24157-18-4
- MF: C15H24N2
- MW: 232.36
- EINECS:
- MDL Number:MFCD06007724
- Synonyms:3-(4-BENZYL-PIPERIDIN-1-YL)-PROPYLAMINE;ASINEX-REAG BAS 12337284;TIMTEC-BB SBB011650;3-[4-(benzyl)-1-piperidyl]propylamine;3-[4-(phenylmethyl)-1-piperidinyl]propan-1-amine;3-[4-(phenylmethyl)-1-piperidyl]propan-1-amine;3-[4-(phenylmethyl)piperidin-1-yl]propan-1-amine;3-(4-benzylpiperidin-1-yl)propan-1-amine
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAK Scientific
- Product number8152AD
- Product description3-(4-Benzyl-piperidin-1-yl)-propylamine
- Packaging1g
- Price$704
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0085088
- Product description3-(4-BENZYL-PIPERIDIN-1-YL)-PROPYLAMINE 95.00%
- Packaging500MG
- Price$777.32
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11160321
- Product description3-(4-Benzylpiperidin-1-yl)propan-1-amine 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number019467
- Product description3-(4-Benzyl-piperidin-1-yl)-propylamine
- Packaging1g
- Price$485
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 8152AD | 3-(4-Benzyl-piperidin-1-yl)-propylamine | 1g | $704 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0085088 | 3-(4-BENZYL-PIPERIDIN-1-YL)-PROPYLAMINE 95.00% | 500MG | $777.32 | 2021-12-16 | Buy |
Crysdot | CD11160321 | 3-(4-Benzylpiperidin-1-yl)propan-1-amine 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 019467 | 3-(4-Benzyl-piperidin-1-yl)-propylamine | 1g | $485 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|